127 related articles for article (PubMed ID: 25126310)
1. Obesity: effective treatment requires change in payers' perspective.
Greenapple R; Ngai J
Am Health Drug Benefits; 2010 Mar; 3(2):88-94. PubMed ID: 25126310
[TBL] [Abstract][Full Text] [Related]
2. Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples.
Brogan AP; DeMuro C; Barrett AM; D'Alessio D; Bal V; Hogue SL
J Manag Care Spec Pharm; 2017 Feb; 23(2):125-134. PubMed ID: 28125369
[TBL] [Abstract][Full Text] [Related]
3. Payer perceptions on the use of economic models in oncology decision making.
Biskupiak J; Oderda G; Brixner D; Burgoyne D; Arondekar B; Niyazov A
J Manag Care Spec Pharm; 2021 Nov; 27(11):1560-1567. PubMed ID: 34714111
[No Abstract] [Full Text] [Related]
4. Trends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providers.
Greenapple R
Am Health Drug Benefits; 2012 Mar; 5(2):83-92. PubMed ID: 24991313
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
[TBL] [Abstract][Full Text] [Related]
6. Payers' Perspectives on Pharmacist-Directed Care in a Community Pharmacy Setting.
Merrill BS; Tak CR; Feehan M; Munger MA
Ann Pharmacother; 2019 Sep; 53(9):916-921. PubMed ID: 30895798
[No Abstract] [Full Text] [Related]
7. Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(22):1-23. PubMed ID: 23074527
[TBL] [Abstract][Full Text] [Related]
8. Payer perceptions on the use of patient-reported outcomes in oncology decision making.
Oderda G; Brixner D; Biskupiak J; Burgoyne D; Arondekar B; Deal LS; Quek RG; Niyazov A
J Manag Care Spec Pharm; 2022 Feb; 28(2):188-195. PubMed ID: 34806908
[No Abstract] [Full Text] [Related]
9. The evolution of payer management of oncology drugs in the United States between 2017 and 2022.
Runyan A; Yi J; Honcz J
J Manag Care Spec Pharm; 2023 Oct; 29(10):1138-1149. PubMed ID: 37695273
[No Abstract] [Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Emerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.
Greenapple R
Am Health Drug Benefits; 2012 Jul; 5(4):242-53. PubMed ID: 24991323
[TBL] [Abstract][Full Text] [Related]
12. A Survey of Payer Perspectives on Cannabis Use Disorder.
Kiselica AM; Duhig A; Montoya I; Skolnick P; Floyd J; Byars C
Subst Use Misuse; 2018 Nov; 53(13):2257-2264. PubMed ID: 29927691
[TBL] [Abstract][Full Text] [Related]
13. Gastric electrical stimulation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
[TBL] [Abstract][Full Text] [Related]
14. Modifier 22 for acetabular fractures in morbidly obese patients: does it affect reimbursement?
Bergin PF; Kneip C; Pierce C; Hendrix ST; Porter SE; Graves ML; Russell GV
Clin Orthop Relat Res; 2014 Nov; 472(11):3370-4. PubMed ID: 24777721
[TBL] [Abstract][Full Text] [Related]
15. Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(8):1-151. PubMed ID: 38130940
[TBL] [Abstract][Full Text] [Related]
16. Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians.
Yang J; Blinzler K; Lankin J; Vijayakumar S; Maculaitis MC; Shelbaya A
BioDrugs; 2022 Jan; 36(1):71-83. PubMed ID: 34822141
[TBL] [Abstract][Full Text] [Related]
17. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States.
Nuijten M; Marczewska A; Araujo Torres K; Rasouli B; Perugini M
J Med Econ; 2018 Sep; 21(9):835-844. PubMed ID: 29678127
[TBL] [Abstract][Full Text] [Related]
18. The Current Status of Outcomes-Based Contracting for Manufacturers and Payers: An AMCP Membership Survey.
Duhig AM; Saha S; Smith S; Kaufman S; Hughes J
J Manag Care Spec Pharm; 2018 May; 24(5):410-415. PubMed ID: 29337604
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
